Hedia Gains Approval to Extend Digital Diabetes Care to Pediatric Patients

Hedia has received regulatory approval to extend its digital diabetes care services to pediatric patients. The updated Medical Device Regulation (MDR) certification now permits the company to offer its digital platform to children with diabetes.

This expansion includes enhancements designed to provide greater support for insulin regimes and improve connectivity with a wider range of devices. The development aims to deliver more comprehensive and personalized assistance to young individuals managing diabetes and their caregivers.

The approval is expected to enable Hedia to broaden its market reach and solidify its position in the digital diabetes management sector. The company seeks to improve the quality of life for people with diabetes through technological solutions.

Further details regarding the rollout timeline for these new pediatric features have not yet been disclosed by the company.